tiprankstipranks
Trending News
More News >

Fagron Releases 2024 Annual Report Ahead of Shareholders’ Meeting

Story Highlights
Fagron Releases 2024 Annual Report Ahead of Shareholders’ Meeting

Confident Investing Starts Here:

The latest update is out from Fagron SA ( (GB:0HNZ) ).

Fagron has released its annual report for 2024, with discussions and approval of the annual accounts scheduled for the shareholders’ meeting in May 2025. This report is available in both Dutch and English on the company’s website, potentially impacting stakeholders by providing insights into the company’s financial health and strategic direction.

More about Fagron SA

Fagron is a leading global company in pharmaceutical compounding, providing personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients across more than 30 countries. The company is based in Nazareth, Belgium, and is listed on Euronext Brussels and Euronext Amsterdam.

YTD Price Performance: 10.35%

Average Trading Volume: 3,203

Technical Sentiment Consensus Rating: Sell

Current Market Cap: €1.34B

Find detailed analytics on 0HNZ stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App